IL TRATTAMENTO CHIRURGICO DELLE METASTASI EPATICHE DA CARCINOMA COLORETTALE

From 1987 to 1991, 45 hepatic resections (of which 18 were major) were performed in 41 patients for treatment of metastases from colorectal carcinoma. The median lollo IV-UP period was 26.8 months. The overall actuarial 3.)ear survival rate was 33.7%; it was 57.1% after treatment of metachronous metastases and 20% after treatment of synchronous ones; 37.5% for solitary metastases and 16.0% for multiple ones. In our experience three Factors correlated significantly with survival after hepatic resection. They were: a) timing of metastasis diagnosis; b) a number of metastases; c) stage of primary colorectal carcinoma. Survival benefits and the improved quality of life justify surgical treatment of IIepatic metastases due to colorectal carcinoma.